Rare diseases
Investigational molecules
Locations
Floor 1st, Limegrove Centre
Medicure International Inc. is involved in clinical research focused on epileptic seizures linked to rare neurological conditions, with particular attention to seizure control in patients affected by Pyridox(am)ine 5’-Phosphate Oxidase (PNPO) deficiency.
The sponsor’s research activity is centered on treatment options for a rare inborn metabolic-neurological disorder that presents with difficult-to-control seizures.
Medicure International Inc. runs clinical trials in conditions such as Seizure, among others.
Clinical trials run by this sponsor – those enrolling participants first.
PolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
